Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cells

Oncogene

Volumn 27, Issue 1, 2008, Pages 1-8

  Zhao, Y ^a   Hamza, M S ^b   Leong, H S ^a   Lim, C B ^a   Pan, Y F ^b   Cheung, E ^b   Soo, K C ^a   Iyer, N G ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

5FU; Bad phosphorylation; KLF5; Survival kinase

Indexed keywords

CELL PROTEIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 5; PROTEIN KINASE PIM 1; PROTEIN P53; SURVIVAL KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL; CARCINOGENESIS; CELL SURVIVAL; CHEMOSENSITIVITY; CHROMATIN IMMUNOPRECIPITATION; DNA DAMAGE; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-ASSOCIATED DEATH PROTEIN; CELL SURVIVAL; DNA DAMAGE; HCT116 CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-PIM-1; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 37849011860     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210625     Document Type: Article

References (34)

1. Aho TL, Sandholm J, Peltola KJ, Mankonen HP, Lilly M, Koskinen PJ. (2004). Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein byphosphory lating it on the Ser112 gatekeeper site. FEBS Lett 571: 43-49.
2. Amaravadi R, Thompson CB. (2005). The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115: 2618-2624.
3. Bateman NW, Tan D, Pestell RG, Black JD, Black AR. (2004). Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem 279: 12093-12101.
4. Bergmann A. (2002). Survival signaling goes BAD. Dev Cell 3: 607-608.
5. Black AR, Black JD, Azizkhan-Clifford J. (2001). Sp1 and Kruppel-like factor familyof transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160.
6. Chao DT, Korsmeyer SJ. (1998). BCL-2 family: regulators of cell death. Annu Rev Immunol 16: 395-419.
7. Chen C, Benjamin MS, Sun X, Otto KB, Guo P, Dong XY et al. (2006). KLF5 promotes cell proliferation and tumorigenesis through gene regulation in the TSU-Pr1 human bladder cancer cell line. Int J Cancer 118: 1346-1355.
8. Chen C, Bhalala HV, Qiao H, Dong JT. (2002). A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 21: 6567-6572.
9. Chen C, Bhalala HV, Vessella RL, Dong JT. (2003). KLF5 is frequentlydeleted and down-regulated but rarelymutated in prostate cancer. Prostate 55: 81-88.
10. Chen C, Sun X, Ran Q, Wilkinson KD, Murphy TJ, Simons JW et al. (2005a). Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene 24: 3319-3327.
11. Chen CN, Lin JJ, Chen JJ, Lee PH, Yang CY, Kuo ML et al. (2005b). Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol 23: 7286-7295.
12. Dong JT. (2001). Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 20: 173-193.
13. Felsher DW. (2003). Cancer revoked: oncogenes as therapeutic targets. Nat Rev Cancer 3: 375-380.
14. Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM, Yang VW. (2005). Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 15: 92-96.
15. Hammerman PS, Fox CJ, Birnbaum MJ, Thompson CB. (2005). Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105: 4477-4483.
16. Iyer NG, Chin SF, Ozdag H, Daigo Y, Hu DE, Cariati M et al. (2004). p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells bymodulation of PUMA/p21 levels. Proc Natl Acad Sci USA 101: 7386-7391.
17. Kaczynski J, Cook T, Urrutia R. (2003). Sp1- and Kruppel-like transcription factors. Genome Biol 4: 206.
18. Kho PS, Wang Z, Zhuang L, Li Y, Chew JL, Ng HH et al. (2004). p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. J Biol Chem 279: 21183-21192.
19. Macdonald A, Campbell DG, Toth R, McLauchlan H, Hastie CJ, Arthur JS. (2006). Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol 7: 1.
20. Meeker TC, Loeb J, Ayres M, Sellers W. (1990). The human Pim-1 gene is selectivelytranscribed in different hematolymphoid cell lines in spite of a G + C-rich housekeeping promoter. Mol Cell Biol 10: 1680-1688.
21. Mitsiades CS, Mitsiades N, Koutsilieris M. (2004). The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets 4: 235-256.
22. Nagai R, Shindo T, Manabe I, Suzuki T, Kurabayashi M. (2003). KLF5/BTEB2, a Kruppel-like zinc-finger type transcription factor, mediates both smooth muscle cell activation and cardiac hypertrophy. Adv Exp Med Biol 538: 57-65. Discussion 66.
23. Nandan MO, Yoon HS, Zhao W, Ouko LA, Chanchevalap S, Yang VW. (2004). Kruppel-like factor 5 mediates the transforming activityof oncogenic H-Ras. Oncogene 23: 3404-3413.
24. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B. (1996). Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10: 1945-1952.
25. Rainio EM, Ahlfors H, Carter KL, Ruuska M, Matikainen S, Kieff E et al. (2005). Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity. Virology 333: 201-206.
26. Ruvolo PP, Deng X, May WS. (2001). Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia 15: 515-522.
27. Safe S, Abdelrahim M. (2005). Sp transcription factor family and its role in cancer. Eur J Cancer 41: 2438-2448.
28. Seoane J, Le HV, Massague J. (2002). Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734.
29. Shi H, Zhang Z, Wang X, Liu S, Teng CT. (1999). Isolation and characterization of a gene encoding human Kruppel-like factor 5 (IKLF): binding to the CAAT/GT box of the mouse lactoferrin gene promoter. Nucleic Acids Res 27: 4807-4815.
30. Sun R, Chen X, Yang VW. (2001). Intestinal-enriched Kruppel-like factor (Kruppel-like factor 5) is a positive regulator of cellular proliferation. J Biol Chem 276: 6897-6900.
31. Suzuki T, Aizawa K, Matsumura T, Nagai R. (2005). Vascular implications of the Kruppel-like familyof transcription factors. Arterioscler Thromb Vasc Biol 25: 1135-1141.
32. Vousden KH, Lu X. (2002). Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604.
33. Yang Y, Goldstein BG, Chao HH, Katz JP. (2005). KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther 4: 1216-1221.
34. Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q. (2005). Inhibitors of histone deacetylases target the Rb-E2F1 pathwayfor apoptosis induction through activation of proapoptotic protein Bim. Proc Natl Acad Sci USA 102: 16090-16095.